School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

GERON CORP GERN

Healthcare · Biotechnology

$1.23last close 2026-10-09 · market cap $787.03M · delayed data

Trailing returns

1M-12.50%
3M-21.47%
6M-30.40%
1Y-11.87%

Basis: Adjusted daily closes.

What it does

Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology.

Open GERN in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies